Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
about
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Sensitivity of (18)F-FDG PET in evaluation of solitary pulmonary nodulesClinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer.The imaging of small pulmonary nodules.Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis.PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide.Decision making in patients with pulmonary nodules.The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CTCharacterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [¹⁸F] fluorodeoxyglucose-positron emission tomography/computed tomography.International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.The value of delayed (18)F FDG-PET imaging in diagnosis of solitary pulmonary nodules: A preliminary study on 28 patientsA comparison of image contrast with (64)Cu-labeled long circulating liposomes and (18)F-FDG in a murine model of mammary carcinoma.Low-dose CT: technique, reading methods and image interpretation.Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications.Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodules.Evaluation of locoregional invasiveness of small-sized non-small cell lung cancers by enhanced dual-energy computed tomography.Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm.Simple pulmonary eosinophilia evaluated by means of FDG PET: the findings of 14 cases.The role of positron emission tomography in the management of non-small cell lung cancer.PET-CT in oncology: making the most of CTCorrelation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesionsThe predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapyNovel molecular imaging in lung and pleural diseases.Initial experience of MR/PET in a clinical cancer center.18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy.Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging.Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.Imaging-guided chest biopsies: techniques and clinical results.Followup of a solid solitary pulmonary nodule with low metabolic activityStandardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients.Value of delayed 18F-FDG PET in the diagnosis of solitary pulmonary nodule.Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging.The advantage of PET and CT integration in examination of lung tumors.Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer.Particle therapy for clinically diagnosed stage I lung cancer: comparison with pathologically proven non-small cell lung cancer.Early lung cancer detection using spiral computed tomography and positron emission tomography.
P2860
Q27025828-8AD14A4C-249F-4503-A991-A8AFCDB42448Q28081859-8C4372FC-0A4F-4833-A730-2D6AC3130A55Q30250349-87889E20-065C-41BA-8119-01C2211539AEQ30360597-2072529C-63F4-401D-97D7-50F3C623EB6EQ33786992-0EBDD2B5-8F5F-439D-9F41-71B6874E8442Q34677001-D4801DB2-C6A4-4E74-A9B6-4698BAC60BE9Q35991264-82A06482-F769-45DB-9F3E-4A0037BF4B77Q36061309-B3A9CCD7-BF2F-430A-9AD1-4B6DCD0D5BB0Q36340523-FC79145E-E1FF-46B3-88F0-5CC671F77E51Q36371292-AD5453DB-1619-4186-814D-80BC86ADA400Q36394204-7607ACF1-83E1-49DD-B636-04F9C1AFC06AQ36533813-31896D4D-5575-4ADC-AD85-32D2D81B5724Q36602229-746739A0-0BA7-4ED1-BC09-DB1F3DCE23BDQ36926680-45B89DE4-4F41-404E-8744-C7012D0B4BCDQ37016566-5A792744-0922-48FD-B98E-B274625BB816Q37063199-2046937C-D76C-4EF2-8816-9C04C4C3F36CQ37106834-AA1BECA2-F3FD-4A8B-95C7-584B5C910C19Q37125992-A4809030-22F0-4DD9-B4D1-CA63C39641DFQ37153378-6D0D8DE6-69CF-4E1C-97B3-467C35E9C21AQ37199250-9CEB74D8-954B-45A8-8963-59E0DF942E2AQ37210598-85F4342B-E8B2-49C1-A9A4-2F4A85813675Q37292842-1E140C45-4D5D-45D2-9C3E-7D876FDC2CE6Q37467864-B051717D-C1CE-4D69-986D-D82C80DE1A4EQ37566016-5B4B7EB3-0075-469C-B295-F28706903808Q37927164-E48EA9DD-1911-4E7F-9FD7-92ED50AC0636Q38134357-4F19EC49-868E-44C0-B87A-D6FE6D4A14A4Q38374483-F2C6AA5B-A311-4D96-A269-CAD32976D463Q38550755-B3F8B782-DA5D-4E09-809C-EAAC46E463F0Q38673721-18441D19-E7C1-41E7-9D26-8C950C313566Q38846611-B724292F-E968-4B25-9108-A8C5D75A0CC7Q39327983-9E5E371D-6899-4F02-868D-6554C4382081Q39389976-46E613FB-8D8F-405C-AF17-5663CBF867AFQ39664938-87BDAFB5-CD82-493C-BC5A-E16C795BA6A1Q41302833-2AB076AE-0958-4ADC-B085-B5E452D8E093Q41375882-48BCCFB1-8171-4412-A4A5-343DBB529963Q41823928-FDBA829E-C055-4547-BD4C-8EA3F1039684Q41952631-A9F54CCA-BBCD-43FE-AB2C-D1983CEFF6DAQ43478685-19BACF29-603E-41E2-B33D-3C50EF73BE6EQ44848976-52139D2E-CFB2-4502-915A-4A75E2D2493FQ46404393-C4EA45FB-972C-4529-8CAC-8439FB62412B
P2860
Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Evaluation of F-18 fluorodeoxy ...... al reference to the CT images.
@en
Evaluation of F-18 fluorodeoxy ...... al reference to the CT images.
@nl
type
label
Evaluation of F-18 fluorodeoxy ...... al reference to the CT images.
@en
Evaluation of F-18 fluorodeoxy ...... al reference to the CT images.
@nl
prefLabel
Evaluation of F-18 fluorodeoxy ...... al reference to the CT images.
@en
Evaluation of F-18 fluorodeoxy ...... al reference to the CT images.
@nl
P2093
P1433
P1476
Evaluation of F-18 fluorodeoxy ...... ial reference to the CT images
@en
P2093
Hiroaki Nomori
Keiichi Suemasu
Kenichi Watanabe
Kimiichi Uno
Tsuguo Naruke
P356
10.1016/J.LUNGCAN.2004.01.009
P577
2004-07-01T00:00:00Z